| A | B | |
|---|---|---|
1 | Notes on how to engage with our cost-effectiveness analysis | |
2 | This workbook contains our cost-effectiveness analysis. Cost-effectiveness is one factor we use to assess which opportunities are the highest-priority to support. We also consider other factors such as urgency, quality of implementation, and more. If you're a donor interested in supporting the top charity we believe will do the most good at the time your donation is granted, please consider supporting the Maximum Impact Fund. On the "Moral weights and discount rate" sheet, we've included GiveWell and conventional estimates for a few parameters. If you'd like to see how our results would change based on different inputs for these parameters, you can make a copy of this spreadsheet and enter your own values in the "Anyone" column. Expanding the formula bar at the top of the page (by clicking and dragging the bottom boundary) may make it easier to read the contents of explanatory cells. | |
3 | ||
4 | ||
5 | ||
6 | Notes on text color coding | |
7 | Blue text: direct input | |
8 | Green text: pulling from another cell in this workbook | |
9 | Black text: calculation | |
10 | ||
11 | Index | |
12 | Moral weights and discount rate | Allows staff members or anyone else to supply discount rates and numbers used to trade off different good outcomes |
13 | AMF | Cost-effectiveness analysis for long-lasting insecticide-treated net distributions by the Against Malaria Foundation. |
14 | GiveDirectly | Cost-effectiveness analysis for unconditional cash transfers by GiveDirectly. |
15 | Deworm the World | Cost-effectiveness analysis for deworming by Deworm the World |
16 | END Fund | Cost-effectiveness analysis for deworming by The END Fund |
17 | SCI Foundation | Cost-effectiveness analysis for deworming by SCI Foundation |
18 | Sightsavers | Cost-effectiveness analysis for deworming by Sightsavers |
19 | Malaria Consortium | Cost-effectiveness analysis for seasonal malaria chemoprevention by Malaria Consortium |
20 | Helen Keller International | Cost-effectiveness analysis for vitamin A supplementation by Helen Keller International |
21 | New Incentives | Cost-effectiveness analysis for conditional cash transfers for immunization by New Incentives |
22 | Value of counterfactual spending by other actors | Used in the leverage and funging adjustments to our cost-effectiveness analyses |
23 | Supplemental intervention-level adjustments | Intervention-level adjustments for outcomes not explicitly modeled in our cost-effectiveness analyses |
24 | ||
25 | Helpful GiveWell references | |
26 | Guide to GiveWell cost-effectiveness analyses | |
27 | Full reviews of our top charities | |
28 | Past versions of our cost-effectiveness analyses | |
29 | Discussion of cost-effectiveness as a criterion | |
30 | Blog posts discussing cost-effectiveness | |